This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
nk cells | 170 |
respiratory syndrome | 115 |
cell lines | 112 |
convalescent plasma | 91 |
radix bupleuri | 85 |
protein sequences | 84 |
acute respiratory | 73 |
goose ifitm | 67 |
type i | 63 |
nk cell | 62 |
ssdna mres | 62 |
tgev pl | 57 |
preparedness activities | 52 |
amino acid | 48 |
severe acute | 47 |
rna recombination | 46 |
ssdna mre | 45 |
respiratory infections | 44 |
porcine reproductive | 44 |
viral rna | 43 |
infectious diseases | 42 |
natural killer | 41 |
infection control | 40 |
healthcare institutions | 40 |
research international | 40 |
biomed research | 40 |
syndrome virus | 40 |
doc id | 39 |
res int | 39 |
int doi | 39 |
cord uid | 39 |
syndrome coronavirus | 39 |
biomed res | 39 |
respiratory tract | 38 |
respiratory viruses | 38 |
dna aptamers | 36 |
cfu ml | 36 |
similarity dissimilarity | 36 |
graphical representation | 35 |
circular tfo | 35 |
sabin poliovirus | 35 |
immune response | 35 |
united states | 35 |
positive selection | 35 |
poliovirus type | 34 |
porcine epidemic | 34 |
time pcr | 33 |
staphylococcus aureus | 33 |
cell line | 33 |
vitro selection | 33 |
saudi arabia | 32 |
present study | 31 |
protein sequence | 31 |
dental students | 31 |
infectious disease | 31 |
epidemic diarrhea | 30 |
beta globin | 30 |
potential pseudoknots | 30 |
middle east | 30 |
novel coronavirus | 30 |
syndromic surveillance | 29 |
respiratory syncytial | 29 |
influenza virus | 29 |
ribosomal frameshifting | 29 |
syncytial virus | 29 |
negative selection | 29 |
free energy | 29 |
viral infections | 28 |
suspected cases | 28 |
east respiratory | 28 |
preparedness phase | 28 |
killer cells | 27 |
monoclonal antibody | 27 |
tumor growth | 27 |
authors declare | 27 |
mres specific | 25 |
preparedness system | 25 |
tumor cells | 25 |
innate immunity | 25 |
risk factors | 24 |
public health | 24 |
dna aptamer | 24 |
high affinity | 24 |
feline infectious | 23 |
vero cells | 23 |
infectious peritonitis | 23 |
thcy level | 22 |
diarrhea virus | 22 |
nucleic acid | 22 |
bactericidal effect | 22 |
magnetic beads | 22 |
tract infections | 21 |
coronavirus disease | 21 |
nuclear translocation | 21 |
focus group | 21 |
frameshift stimulator | 20 |
pseudoknots within | 20 |
probe sets | 20 |
positive results | 20 |
viral infection | 20 |
important role | 20 |
ifitm ifitm | 20 |
closely related | 20 |
serum thcy | 20 |
relapse incidence | 19 |
amino acids | 19 |
log cfu | 19 |
polymerase chain | 19 |
genital condylomatosis | 19 |
multiplex real | 19 |
confirmed cases | 19 |
virus infection | 19 |
innate immune | 19 |
bupleurum chinense | 19 |
frameshift site | 18 |
encephalitis virus | 18 |
feline coronavirus | 18 |
balkan endemic | 18 |
mosquito cells | 18 |
frameshift stimulating | 18 |
ben patients | 18 |
statistically significant | 18 |
chain reaction | 18 |
endemic nephropathy | 18 |
slippery sequence | 18 |
conjunctival congestion | 18 |
respiratory pathogens | 18 |
immune system | 17 |
previous studies | 17 |
conjunctival swab | 17 |
logistic regression | 17 |
virus type | 17 |
antiviral activity | 17 |
best candidate | 17 |
severe sepsis | 17 |
stranded dna | 17 |
dendritic cells | 17 |
signaling pathway | 17 |
conjunctivitis conjunctival | 17 |
gold nanoparticles | 17 |
pcr tests | 17 |
respiratory infection | 16 |
swab samples | 16 |
type ii | 16 |
ifn induction | 16 |
citation classics | 16 |
high specificity | 16 |
combination therapy | 16 |
cancer cells | 16 |
ct scan | 16 |
control group | 15 |
bactericidal activity | 15 |
recode database | 15 |
mammalian cells | 15 |
selected mre | 15 |
surveillance system | 15 |
hospitalized children | 15 |
culture medium | 15 |
stranded rna | 15 |
precision medicine | 15 |
virus titer | 15 |
tfo rnas | 15 |
identify ssdna | 15 |
ambulance services | 15 |
viral replication | 15 |
human coronavirus | 15 |
mental health | 15 |
viral etiology | 15 |
rna viruses | 15 |
calculated free | 15 |
resident nk | 15 |
mre specific | 15 |
sars coronavirus | 15 |
nanomolar range | 15 |
mean age | 15 |
viral vaccines | 15 |
rna pseudoknot | 15 |
sars outbreaks | 15 |
rna pseudoknots | 14 |
rna virus | 14 |
dna sequences | 14 |
world health | 14 |
detected pseudoknots | 14 |
acquired pneumonia | 14 |
kcal mol | 14 |
control measures | 14 |
tumor cell | 14 |
candidate mre | 14 |
cutaneous manifestations | 14 |
passive immunization | 14 |
phu sa | 14 |
abdominal aortic | 14 |
clinical trials | 14 |
phylogenetic analysis | 14 |
detected downstream | 14 |
copy number | 14 |
ocular symptoms | 14 |
prevalence rate | 13 |
stimulator pseudoknots | 13 |
healthcare institution | 13 |
data collection | 13 |
pooled prevalence | 13 |
side effects | 13 |
candidate mres | 13 |
standard deviation | 13 |
i ifn | 13 |
viral genome | 13 |
sensitive detection | 13 |
japanese encephalitis | 13 |
monoclonal antibodies | 13 |
cited articles | 13 |
immunodeficiency virus | 13 |
peripheral blood | 13 |
chinense dc | 13 |
cancer therapy | 13 |
may also | 13 |
i ifns | 13 |
copy numbers | 13 |
leukemia virus | 13 |
sequence alignment | 13 |
previous study | 13 |
spike protein | 13 |
pedv strains | 13 |
aortic aneurysm | 13 |
combination therapies | 13 |
sari ards | 13 |
mainland china | 13 |
virus replication | 13 |
human respiratory | 13 |
possible pseudoknots | 13 |
among dental | 12 |
peritonitis virus | 12 |
infected cells | 12 |
additional file | 12 |
binding activities | 12 |
binding affinity | 12 |
lung injury | 12 |
clinical characteristics | 12 |
ifn signaling | 12 |
fractional order | 12 |
tfo rna | 12 |
study showed | 12 |
centralized care | 12 |
widely used | 12 |
systematic review | 12 |
candidate sequences | 12 |
fcov sequences | 12 |
intensity level | 12 |
stimulating pseudoknots | 12 |
pol frameshift | 12 |
academic hospitals | 12 |
immune responses | 12 |
prescription surveillance | 12 |
cell division | 12 |
lung cancer | 12 |
adjacency vector | 12 |
tmuv infection | 12 |
extracellular matrix | 12 |
endothelial cells | 12 |
i interferon | 12 |
nonstructural protein | 12 |
triple helix | 12 |
group representative | 12 |
severe respiratory | 11 |
mathematical models | 11 |
na cells | 11 |
host innate | 11 |
selection sites | 11 |
mycobacterium tuberculosis | 11 |
coronavirus infection | 11 |
expression levels | 11 |
capillary electrophoresis | 11 |
listeria monocytogenes | 11 |
loop lengths | 11 |
cell types | 11 |
dissimilarity analysis | 11 |
detection assay | 11 |
preparedness phases | 11 |
phylogenetic tree | 11 |
determine whether | 11 |
viral genomic | 11 |
immune cells | 11 |
health organization | 11 |
host cells | 11 |
results showed | 11 |
positive rate | 11 |
herpes simplex | 11 |
general practitioners | 11 |
pedv cotopaxi | 11 |
dengue virus | 11 |
type pseudoknots | 11 |
therapeutic agents | 11 |
human immunodeficiency | 11 |
i fcov | 11 |
municipal health | 11 |
sample set | 11 |
resistant staphylococcus | 11 |
prrsv infection | 11 |
bupleuri radix | 10 |
disease control | 10 |
low cross | 10 |
infections caused | 10 |
bacterial count | 10 |
graphene oxide | 10 |
stop codon | 10 |
rna sequence | 10 |
target region | 10 |
simplex virus | 10 |
genomic mrnas | 10 |
parainfluenza virus | 10 |
sequences based | 10 |
breast cancer | 10 |
mortality rate | 10 |
interests regarding | 10 |
high viral | 10 |
system biology | 10 |
fipv replication | 10 |
vaccine production | 10 |
cov infection | 10 |
health services | 10 |
ards cases | 10 |
uterine nk | 10 |
studies showed | 10 |
large number | 10 |
pseudomonas aeruginosa | 10 |
specificity toward | 10 |
mre based | 10 |
intensive care | 10 |
influenza viruses | 10 |
day th | 10 |
identified ssdna | 10 |
molecular recognition | 10 |
two different | 10 |
stimulator pseudoknot | 10 |
different cell | 10 |
ebola virus | 10 |
cutaneous lesions | 9 |
clinical presentation | 9 |
membrane proteins | 9 |
influenza infection | 9 |
salmonella typhimurium | 9 |
silico experiments | 9 |
supplementary material | 9 |
similarity analysis | 9 |
frameshifting efficiency | 9 |
recent years | 9 |
patients treated | 9 |
free detection | 9 |
escherichia coli | 9 |
pcr assay | 9 |
sequence comparison | 9 |
viral load | 9 |
genetic material | 9 |
sabin type | 9 |
infected patients | 9 |
gene expression | 9 |
chemical toxins | 9 |
among children | 9 |
phase orange | 9 |
genital warts | 9 |
age group | 9 |
children hospitalized | 9 |
least one | 9 |
upper respiratory | 9 |
plasma therapy | 9 |
viral rnas | 9 |
rapid detection | 9 |
cell development | 9 |
protective effect | 9 |
ifn production | 9 |
table shows | 9 |
informed consent | 9 |
ssdna aptamers | 9 |
viral copy | 9 |
plasma treatment | 9 |
aortic aneurysms | 9 |
transmissible gastroenteritis | 9 |
representative vector | 9 |
healthcare workers | 9 |
adaptive immune | 9 |
ng ml | 9 |
selected ssdna | 9 |
chinese herbal | 9 |
clinical practice | 9 |
human papillomavirus | 9 |
reported lod | 9 |
neutralizing antibodies | 9 |
gastroenteritis virus | 9 |
viral pathogens | 9 |
positively selected | 9 |
target groups | 9 |
potential pseudoknot | 9 |
target binding | 9 |
extension degree | 9 |
higher risk | 9 |
ssdna library | 9 |
pharmacological effects | 9 |
pro frameshift | 8 |
special issue | 8 |
collaborative preparedness | 8 |
essential oil | 8 |
citation count | 8 |
hemorrhagic fever | 8 |
accession numbers | 8 |
also showed | 8 |
na cell | 8 |
nd protein | 8 |
also reported | 8 |
twelve rounds | 8 |
tembusu virus | 8 |
muscle cells | 8 |
kidney disease | 8 |
suspension cell | 8 |
smooth muscle | 8 |
molecular mechanisms | 8 |
respiratory virus | 8 |
medical records | 8 |
conventional nk | 8 |
incubation period | 8 |
supplementary materials | 8 |
ia will | 8 |
reverse transcriptase | 8 |
end rna | 8 |
prevalence rates | 8 |
virus detection | 8 |
plasma transfusion | 8 |
may contribute | 8 |
different strains | 8 |
reference strain | 8 |
globin protein | 8 |
previously described | 8 |
ocular transmission | 8 |
first time | 8 |
diagnosis kit | 8 |
united kingdom | 8 |
clinical isolates | 8 |
avian influenza | 8 |
target regions | 8 |
respiratory viral | 8 |
protein i | 8 |
acute lung | 8 |
sandwich assay | 8 |
negative bacteria | 8 |
growth fraction | 8 |
lymph nodes | 8 |
respiratory distress | 8 |
cells respond | 8 |
negative targets | 8 |
exposure history | 8 |
control study | 8 |
multiple sequence | 8 |
fractional derivatives | 8 |
virus disease | 8 |
killer cell | 8 |
cancer biology | 8 |
another study | 8 |
pcr amplification | 8 |
gene sequences | 8 |
lightcycler multiplex | 8 |
evd outbreak | 8 |
sarcoma virus | 8 |
lower respiratory | 8 |
cancer cell | 8 |
multiplex rna | 8 |
irf phosphorylation | 8 |
duck ifitm | 8 |
ill patients | 8 |
feline enteric | 8 |
model parameters | 8 |
stimulating pseudoknot | 8 |
circular tfos | 8 |
bupleurum scorzonerifolium | 8 |
toxoplasma gondii | 8 |
pcr method | 8 |
care unit | 8 |
target selection | 8 |
mouse model | 8 |
mucosal tissues | 8 |
cells may | 8 |
selex process | 8 |
two types | 8 |
highly specific | 8 |
mechanical strength | 8 |
pigmy chimpanzee | 8 |
secondary lymphoid | 8 |
significantly higher | 8 |
also shown | 8 |
mathematical model | 8 |
prrsv replication | 8 |
virus master | 8 |
reported values | 8 |
differential equations | 7 |
prrsv strains | 7 |
foreign body | 7 |
multivariate logistic | 7 |
interferon regulatory | 7 |
bactericidal agents | 7 |
vascular remodeling | 7 |
reading frame | 7 |
genetic diversity | 7 |
progrowth signal | 7 |
infection prevention | 7 |
ribosomal frameshift | 7 |
magnetic bead | 7 |
comparative analysis | 7 |
vero cell | 7 |
antibiotic therapy | 7 |
inflammatory cytokines | 7 |
physical dimensions | 7 |
diploid cell | 7 |
protease domain | 7 |
negative results | 7 |
current study | 7 |
immature nk | 7 |
significant differences | 7 |
host cell | 7 |
transmission dynamics | 7 |
sequences obtained | 7 |
bovine serum | 7 |
based electrochemical | 7 |
electrochemical aptasensor | 7 |
cells transfected | 7 |
performed using | 7 |
step rt | 7 |
coated magnetic | 7 |
two groups | 7 |
mycoplasma pneumoniae | 7 |
tract infection | 7 |
risk factor | 7 |
cytolytic activity | 7 |
open reading | 7 |
clinical trial | 7 |
pulmonary disease | 7 |
see table | 7 |
human cd | 7 |
laboratory screening | 7 |
ii fcov | 7 |
basal segment | 7 |
study conducted | 7 |
streptavidin coated | 7 |
gut mucosal | 7 |
like receptors | 7 |
secondary structure | 7 |
interest regarding | 7 |
terminal region | 7 |
per well | 7 |
small intestine | 7 |
genital areas | 7 |
mediated immune | 7 |
transmembrane proteins | 7 |
gel electrophoresis | 7 |
among different | 7 |
quantitative pcr | 7 |
adverse events | 7 |
combined intensity | 7 |
peripheral hospitals | 7 |
ng per | 7 |
growth factor | 7 |
cd bright | 7 |
hematopoietic cell | 7 |
regulatory factor | 7 |
relatively low | 7 |
multiplex pcr | 7 |
distress syndrome | 7 |
three groups | 7 |
new cell | 7 |
complete genome | 7 |
dissimilarity matrix | 7 |
wide range | 7 |
nine nd | 7 |
phase yellow | 7 |
respiratory disease | 7 |
commonly used | 7 |
cohort study | 7 |
cells play | 7 |
binding activity | 7 |
body sensation | 7 |
mass spectrometry | 7 |
length genomic | 7 |
default ranges | 7 |
thoracoabdominal aortic | 7 |
genome sequence | 7 |
random region | 7 |
dependent manner | 7 |
nsp inhibits | 7 |
dna sequence | 7 |
cell responses | 7 |
iii one | 7 |
per preparedness | 7 |
adaptive evolution | 7 |
detection system | 7 |
rna fragments | 7 |
target bacteria | 7 |
na daughter | 7 |
sectional study | 7 |
antimicrobial peptides | 7 |
activities per | 7 |
balkan nephropathy | 7 |
even though | 7 |
recent studies | 7 |
within days | 7 |
two stems | 7 |
ocular surface | 7 |
rna extracted | 7 |
different mechanisms | 7 |
whether tgev | 7 |
hospitalized due | 7 |
sars transmission | 7 |
transmembrane protein | 7 |
daughter cells | 7 |
psychosocial risks | 7 |
cells infected | 7 |
rna amount | 7 |
cell populations | 7 |
liver injury | 7 |
identified within | 7 |
glass opacity | 7 |
assay showed | 7 |
early phase | 7 |
recognition elements | 7 |
bone marrow | 7 |
institutional preparedness | 6 |
viral respiratory | 6 |
time rt | 6 |
nucleic acids | 6 |
bibliometric analysis | 6 |
study revealed | 6 |
gold nanoparticle | 6 |
different respiratory | 6 |
qpcr assay | 6 |
time points | 6 |
antibacterial agents | 6 |
dna replication | 6 |
two methods | 6 |
fully human | 6 |
vitro antiviral | 6 |
harderian gland | 6 |
mucosal tissue | 6 |
recent study | 6 |
drug administration | 6 |
early control | 6 |
multiple viral | 6 |
mrsa sa | 6 |
studies reported | 6 |
several studies | 6 |
unfolding threat | 6 |
ten rounds | 6 |
square test | 6 |
clostridium difficile | 6 |
two rounds | 6 |
forming oligonucleotides | 6 |
analysis showed | 6 |
infected people | 6 |
livedo reticularis | 6 |
murine leukemia | 6 |
prrsv proteins | 6 |
reading frames | 6 |
internal control | 6 |
rna genome | 6 |
inflammatory response | 6 |
viral strains | 6 |
passaged sabin | 6 |
ii rv | 6 |
empty space | 6 |
authors reported | 6 |
energy value | 6 |
chronic kidney | 6 |
like receptor | 6 |
give rise | 6 |
nucleotide sequences | 6 |
significant difference | 6 |
reproductive tract | 6 |
different physical | 6 |
showed low | 6 |
plasmacytoid dendritic | 6 |
triplex formation | 6 |
lymph node | 6 |
detection using | 6 |
two databases | 6 |
detection methods | 6 |
traditional uses | 6 |
genbank database | 6 |
activated signaling | 6 |
cysteine protease | 6 |
lower lobe | 6 |
initial ct | 6 |
cdna synthesis | 6 |
adjacency vectors | 6 |
different master | 6 |
antibacterial activity | 6 |
sample size | 6 |
molecular epidemiology | 6 |
receptor binding | 6 |
readthrough stimulator | 6 |
negative selections | 6 |
respiratory symptoms | 6 |
carbon nanotubes | 6 |
order derivative | 6 |
crfk cells | 6 |
cell culture | 6 |
traditional chinese | 6 |
outer membrane | 6 |
antimicrobial agents | 6 |
initial presentation | 6 |
early stage | 6 |
antiviral properties | 6 |
protein ii | 6 |
fluorescence polarization | 6 |
threatening covid | 6 |
regression models | 6 |
lung tissue | 6 |
bacterial infections | 6 |
significant upregulation | 6 |
local alignment | 6 |
irf activation | 6 |
blood cultures | 6 |
requiring centralized | 6 |
antibacterial effect | 6 |
viral genomes | 6 |
basic science | 6 |
health care | 6 |
genomic rna | 6 |
helical stems | 6 |
bupleurum species | 6 |
also performed | 6 |
based biosensors | 6 |
kg cells | 6 |
master mixes | 6 |
human cell | 6 |
previous report | 6 |
infected class | 6 |
dissimilarity vector | 6 |
detection limit | 6 |
sequence length | 6 |
dub activity | 6 |
cell lung | 6 |
growth factors | 6 |
production processes | 6 |
equine encephalitis | 6 |
forming oligonucleotide | 6 |
st century | 6 |
sars outbreak | 6 |
clinical manifestations | 6 |
ct features | 6 |
binding assay | 6 |
mres targeting | 6 |
positive cases | 6 |
linear tfo | 6 |
health problems | 6 |
total rna | 6 |
population movement | 6 |
mabs development | 6 |
chicken ifitm | 6 |
hpv infection | 6 |
nsp genes | 6 |
frameshift signal | 6 |
passaged virus | 6 |
euclidean distance | 6 |
fixed point | 6 |
first line | 6 |
enteric coronavirus | 6 |
echinacea purpurea | 6 |
pdm infection | 6 |
nk precursor | 6 |
much higher | 6 |
active phase | 6 |
signal amplification | 6 |
low nanomolar | 6 |
also found | 6 |
mucosal sites | 6 |
antimicrobial activity | 6 |
signal transduction | 6 |
effect model | 6 |
cell wall | 6 |
reverse transcription | 6 |
critically ill | 6 |
human parainfluenza | 6 |
urinary tract | 6 |
impact factor | 6 |
protein expression | 5 |
medical city | 5 |
surveillance systems | 5 |
unrest among | 5 |
european countries | 5 |
infection among | 5 |
structural proteins | 5 |
gondii infection | 5 |
results suggested | 5 |
pcr analysis | 5 |
study provides | 5 |
novel mechanism | 5 |
nadh dehydrogenase | 5 |
general hospital | 5 |
smear cultures | 5 |
important roles | 5 |
biosensing application | 5 |
dehydrogenase subunit | 5 |
cell type | 5 |
antigen level | 5 |
epidemiological characteristics | 5 |
different types | 5 |
induced transmembrane | 5 |
high expression | 5 |
eye itching | 5 |
national institute | 5 |
electrochemical biosensor | 5 |
one solution | 5 |
computer program | 5 |
protein kinase | 5 |
exome sequencing | 5 |
antiviral drugs | 5 |
fold higher | 5 |
magnetic resonance | 5 |
alpha toxin | 5 |
analyzed using | 5 |
selected sample | 5 |
first year | 5 |
like protease | 5 |
chest ct | 5 |
nonstructural proteins | 5 |
gastrointestinal tract | 5 |
highest articles | 5 |
binding data | 5 |
university hospital | 5 |
protein alignment | 5 |
artificially contaminated | 5 |
binary toxin | 5 |
small number | 5 |
folic acid | 5 |
tract tissues | 5 |
rous sarcoma | 5 |
proinflammatory cytokines | 5 |
phase red | 5 |
inhibit ifn | 5 |
anyplex ii | 5 |
electrochemical detection | 5 |
essential oils | 5 |
ranked st | 5 |
results suggest | 5 |
increased secretion | 5 |
gene based | 5 |
sequence elements | 5 |
mbc values | 5 |
cell substrates | 5 |
antimicrobial susceptibility | 5 |
hong kong | 5 |
ct findings | 5 |
south korea | 5 |
common respiratory | 5 |
yl benzamides | 5 |
categorical variables | 5 |
severe influenza | 5 |
case series | 5 |
significance analyses | 5 |
prostate cancer | 5 |
pseudoknots identified | 5 |
infections among | 5 |
results may | 5 |
basic local | 5 |
recognition receptors | 5 |
first reported | 5 |
inflammatory cells | 5 |
antiviral function | 5 |
whole cell | 5 |
microbiological examinations | 5 |
mediated innate | 5 |
surface plasmon | 5 |
species transmission | 5 |
transcription factor | 5 |
st among | 5 |
viral entry | 5 |
severe pneumonia | 5 |
wild type | 5 |
loop structure | 5 |
whole blood | 5 |
relatively high | 5 |
one na | 5 |
eight rounds | 5 |
convalescent serum | 5 |
ia cells | 5 |
healthy controls | 5 |
body mass | 5 |
crystal structure | 5 |
pooled positive | 5 |
stem free | 5 |
lo cd | 5 |
polyacrylamide gel | 5 |
simultaneous detection | 5 |
sars spread | 5 |
full genome | 5 |
sequences using | 5 |
many patients | 5 |
interview round | 5 |
regression model | 5 |
starting inoculum | 5 |
traditional microbiological | 5 |
aptamer biosensor | 5 |
mutually excluded | 5 |
obtained results | 5 |
class i | 5 |
han population | 5 |
rna polymerase | 5 |
produce ifn | 5 |
putative frameshift | 5 |
dynamic representation | 5 |
disease virus | 5 |
early detection | 5 |
cell selex | 5 |
cecal tonsil | 5 |
quantitative measures | 5 |
female reproductive | 5 |
regression analysis | 5 |
west nile | 5 |
pneumoniae infection | 5 |
phased preparedness | 5 |
interaction analyses | 5 |
cancer therapies | 5 |
candidate ssdna | 5 |
qassim regions | 5 |
fatality rate | 5 |
also known | 5 |
human lung | 5 |
sensitivity analysis | 5 |
red wine | 5 |
water samples | 5 |
cluster included | 5 |
triterpenoid saponins | 5 |
acid mres | 5 |
pleural effusion | 5 |
enhanced preparedness | 5 |
streptococcus pyogenes | 5 |
pseudoknots ranked | 5 |
tissue specific | 5 |
pcr testing | 5 |
helix forming | 5 |
clinical symptoms | 5 |
postpandemic period | 5 |
one patient | 5 |
target detection | 5 |
vascular injury | 5 |
calculated using | 5 |
adult respiratory | 5 |
sequence similarity | 5 |
genomic rnas | 5 |
patients infected | 5 |
total number | 5 |
infected cats | 5 |
simple stem | 5 |
key role | 5 |
cells ml | 5 |
slightly lower | 5 |
air bronchogram | 5 |
minimal binding | 5 |
immune defense | 5 |
conformational change | 5 |
strand cdna | 5 |
severe cases | 5 |
nile virus | 5 |
pcr system | 5 |
host immune | 5 |
fipv genome | 5 |
one database | 5 |
pediatric patients | 5 |
healthy population | 5 |
gallus gallus | 5 |
numerical characterization | 5 |
mature phenotype | 5 |
cells via | 5 |
fold change | 5 |
detection method | 5 |
wine ochratoxin | 5 |
parasitic infection | 5 |
human blood | 5 |
infectious agents | 5 |
selected sites | 5 |
serum albumin | 5 |
lines tested | 5 |
median age | 5 |
aptasensor based | 5 |
first step | 5 |
translating ribosomes | 5 |
mechanisms behind | 5 |
highly infectious | 5 |
included isolates | 5 |
respiratory samples | 5 |
contributed equally | 5 |
without taaas | 5 |
cited papers | 5 |
causative pathogens | 5 |
inoculated cells | 5 |
cd lo | 5 |
prrsv nsp | 5 |
division probability | 5 |
also important | 5 |
many studies | 5 |
seasonal influenza | 5 |
nine beta | 5 |
antiviral effects | 5 |
several limitations | 5 |
cell surface | 5 |
small molecule | 5 |
potential therapeutic | 5 |
time consuming | 5 |
covariance model | 5 |
significantly lower | 5 |
immune inflammatory | 5 |
permanent residence | 5 |
dna polymerase | 5 |
virus discovery | 5 |
alveolar macrophages | 5 |
results indicated | 5 |
virus infections | 5 |
exponential enrichment | 5 |
assay based | 5 |
light scattering | 5 |
three different | 5 |
double helix | 5 |
human antibodies | 5 |
hl cells | 5 |
innate lymphoid | 5 |
cd hi | 5 |
reverse primer | 5 |
fluorescent assay | 5 |
significant reduction | 5 |
data analysis | 5 |
plasmon resonance | 5 |
codon readthrough | 5 |
phylogenetic trees | 5 |
dna molecular | 5 |
ko mice | 5 |
detection range | 5 |
type iv | 5 |
genome sequences | 5 |
tfo showed | 5 |
genetic predisposition | 5 |
biological sequences | 5 |
chinese han | 5 |
new coronavirus | 5 |
interstitial fibrosis | 5 |
first described | 5 |
ifn antagonist | 5 |
also observed | 5 |
vitro studies | 5 |
jak stat | 5 |
dental health | 5 |
emerging infectious | 5 |
mediated signaling | 5 |
primer pair | 5 |
except tfo | 5 |
ifn expression | 5 |
science foundation | 5 |
testing capacity | 5 |
precursor cells | 4 |
human suspension | 4 |
requires centralized | 4 |
causative agent | 4 |
protective antigen | 4 |
vector composed | 4 |
campylobacter jejuni | 4 |
third year | 4 |
study aimed | 4 |
cellular lysates | 4 |
i signaling | 4 |
rapid rsv | 4 |
liaoning province | 4 |
considered significant | 4 |
potential frameshift | 4 |
kai cao | 4 |
stat signaling | 4 |
virus strains | 4 |
immune plasma | 4 |
protective effects | 4 |
hrsv genotypes | 4 |
graphical representations | 4 |
viral pathogen | 4 |
target group | 4 |
nucleotide level | 4 |
coronavirus isolates | 4 |
continuous cell | 4 |
rna fragment | 4 |
low micromolar | 4 |
inhibitory effect | 4 |
medical facilities | 4 |
environmental factors | 4 |
botulinum neurotoxin | 4 |
patients without | 4 |
blood pressure | 4 |
influenza pandemic | 4 |
health service | 4 |
two helical | 4 |
lung nk | 4 |
transfected cells | 4 |
bioactive compounds | 4 |
central role | 4 |
medical sciences | 4 |
nasopharyngeal carcinoma | 4 |
potential role | 4 |
poliovirus infection | 4 |
academic hospital | 4 |
lower lobes | 4 |
acid testing | 4 |
analysis among | 4 |
highly conserved | 4 |
sars cov | 4 |
high virus | 4 |
study also | 4 |
cell response | 4 |
protein primary | 4 |
end sequence | 4 |
rna isolation | 4 |
virus inoculated | 4 |
host defense | 4 |
first case | 4 |
demographic characteristics | 4 |
psychosocial risk | 4 |
medical institutions | 4 |
cancer patients | 4 |
spatial heterogeneity | 4 |
three candidate | 4 |
possible combination | 4 |
starting point | 4 |
vaccine strain | 4 |
diagnostic kits | 4 |
barr virus | 4 |
ct images | 4 |
cellular automaton | 4 |
hepatocellular carcinoma | 4 |
two na | 4 |
performance liquid | 4 |
oi kuan | 4 |
based detection | 4 |
roadblocking effect | 4 |
calculated stem | 4 |
three primer | 4 |
adenovirus diagnosis | 4 |
eight mabs | 4 |
survival rate | 4 |
copies reaction | 4 |
homologous proteins | 4 |
intestinal mucosa | 4 |
immunological diseases | 4 |
included studies | 4 |
ischemic stroke | 4 |
vice versa | 4 |
phylogenetic analyses | 4 |
highest impact | 4 |
viral pneumonia | 4 |
bd group | 4 |
stat stat | 4 |
rapid diagnosis | 4 |
iv secretion | 4 |
reported results | 4 |
structurally similar | 4 |
human health | 4 |
induced liver | 4 |
data suggest | 4 |
will help | 4 |
new descriptor | 4 |
clinical studies | 4 |
roadblocking pseudoknots | 4 |
studied tissue | 4 |
parenchymal bands | 4 |
antiviral effect | 4 |
including age | 4 |
viral hemorrhagic | 4 |
molecular weight | 4 |
frequently cited | 4 |
signaling pathways | 4 |
ethanol extract | 4 |
riyadh regional | 4 |
cells will | 4 |
human serum | 4 |
identify mres | 4 |
bead based | 4 |
epidemiological data | 4 |
sequences used | 4 |
assay kit | 4 |
identified pseudoknots | 4 |
pam cells | 4 |
replication process | 4 |
significantly different | 4 |
swine influenza | 4 |
nucleotide sequence | 4 |
spike glycoprotein | 4 |
therapy effectiveness | 4 |
considered statistically | 4 |
acid test | 4 |
future research | 4 |
inhibits irf | 4 |
fractional differential | 4 |
hepatitis virus | 4 |
therapy strategies | 4 |
aureus reference | 4 |
liquid chromatography | 4 |
inducible transmembrane | 4 |
frameshift junction | 4 |
performed rounds | 4 |
hi cd | 4 |
assay using | 4 |
human metapneumovirus | 4 |
king abdul | 4 |
lymphoid tissues | 4 |
genome copy | 4 |
human mabs | 4 |
destructive therapy | 4 |
plasma administration | 4 |
counter target | 4 |
virus titers | 4 |
deleterious damaging | 4 |
viral nucleic | 4 |
healthy class | 4 |
ocular manifestations | 4 |
different tissues | 4 |
bacteriostatic effect | 4 |
inhibit fipv | 4 |
activities toward | 4 |
highest cited | 4 |
viral titers | 4 |
shed light | 4 |
top cited | 4 |
genetic variability | 4 |
restriction enzyme | 4 |
pseudoknots detected | 4 |
stable pseudoknot | 4 |
acid adjacency | 4 |
initial symptom | 4 |
structural differences | 4 |
vascular smooth | 4 |
walled carbon | 4 |
neuroendocrine cells | 4 |
posterior probability | 4 |
previously reported | 4 |
necrosis factor | 4 |
rna structure | 4 |
different countries | 4 |
two decades | 4 |
therapeutic effect | 4 |
different target | 4 |
epithelial cells | 4 |
statistical analyses | 4 |
liquid chromatographic | 4 |
least two | 4 |
experiments showed | 4 |
many countries | 4 |
mbc assay | 4 |
genus flavivirus | 4 |
bayesian phylogenetic | 4 |
time domain | 4 |
antipyretic effect | 4 |
vascular disease | 4 |
infection caused | 4 |
applied biosystems | 4 |
authors read | 4 |
authors claimed | 4 |
two ssdna | 4 |
st ranked | 4 |
affect tumor | 4 |
drinking habit | 4 |
molecular characterization | 4 |
anas platyrhynchos | 4 |
detection systems | 4 |
corresponding author | 4 |
statistical analysis | 4 |
suspected fip | 4 |
first study | 4 |
moloney murine | 4 |
general population | 4 |
national level | 4 |
various tissues | 4 |
statistical significance | 4 |
etiological factor | 4 |
specific antibodies | 4 |
rna aptamer | 4 |
first report | 4 |
th among | 4 |
lymphoid structures | 4 |
interferon antagonism | 4 |
six rounds | 4 |
study period | 4 |
continuous variable | 4 |
virus entry | 4 |
redox label | 4 |
tandem pseudoknots | 4 |
human astrovirus | 4 |
cells also | 4 |
among hospitalized | 4 |
different regions | 4 |
cytopathic effects | 4 |
mass index | 4 |
rna mres | 4 |
lymphoid cells | 4 |
count ranging | 4 |
tertiary care | 4 |
independent risk | 4 |
study included | 4 |
minor groove | 4 |
diagnostic tests | 4 |
structure downstream | 4 |
physicochemical properties | 4 |
corona virus | 4 |
three sets | 4 |
chinese pharmacopoeia | 4 |
review board | 4 |
fractional derivative | 4 |
probe set | 4 |
continuous variables | 4 |
may result | 4 |
systematic evolution | 4 |
molecular biology | 4 |
pattern recognition | 4 |
chao xiang | 4 |
developed using | 4 |
virus particle | 4 |
high doses | 4 |
pol genes | 4 |
also demonstrated | 4 |
ssdna molecules | 4 |
high mortality | 4 |
detection kit | 4 |
gas chromatography | 4 |
bayesian maximum | 4 |
acid sequences | 4 |
treatment approach | 4 |
patients showed | 4 |
plasma donation | 4 |
ards series | 4 |
cell leukemia | 4 |
cryptococcus neoformans | 4 |
results indicate | 4 |
database search | 4 |
skin lesions | 4 |
data used | 4 |
lelystad virus | 4 |
infection date | 4 |
spatial correlation | 4 |
lipoprotein cholesterol | 4 |
host antiviral | 4 |
great importance | 4 |
type pseudoknot | 4 |
regional communicable | 4 |
cell recruitment | 4 |
performed another | 4 |
search tool | 4 |
patent applications | 4 |
francisella tularensis | 4 |
blood cells | 4 |
lambda exonuclease | 4 |
sa primer | 4 |
genomic mrna | 4 |
relative expression | 4 |
one hundred | 4 |
respiratory illness | 4 |
antibody therapeutics | 4 |
trigger preparedness | 4 |
biological activities | 4 |
rates due | 4 |
sequence homology | 4 |
antiviral functions | 4 |
ethics committee | 4 |
clinical presentations | 4 |
nakayama strain | 4 |
gene mrna | 4 |
genetic studies | 4 |
ingelvac prrs | 4 |
assessed using | 4 |
influenza pneumonia | 4 |
vesicular lesions | 4 |
affinity toward | 4 |
express cd | 4 |
supporting information | 4 |
symptom onset | 4 |
antimicrobial activities | 4 |
significantly reduced | 4 |
viral disease | 4 |
tissue resident | 4 |
common cold | 4 |
rna interference | 4 |
human diploid | 4 |
brucella species | 4 |
posterior probabilities | 4 |
northern italy | 4 |
detection rates | 4 |
pol junction | 4 |
currently used | 4 |
high level | 4 |
measured according | 4 |
free selex | 4 |
negative target | 4 |
disulphide bonds | 4 |
cells saikosaponin | 4 |
deficient mice | 4 |
spike proteins | 4 |
luciferase reporter | 4 |
hospital admission | 4 |
nucleocapsid protein | 4 |
severe infectious | 4 |
animal viruses | 4 |
case group | 4 |
final manuscript | 4 |
endoplasmic reticulum | 4 |
termination codon | 4 |
recovered patients | 4 |
point theorem | 4 |
untranslated region | 4 |
current evidence | 4 |
pdm virus | 4 |
national health | 4 |
nasal smear | 4 |
ilc populations | 4 |
taaa formation | 4 |
cutaneous presentations | 4 |
maximum entropy | 4 |
cancer hallmarks | 4 |
human therapeutic | 4 |
may help | 4 |
related ifitms | 4 |
hrsv infections | 4 |
rnase cleavage | 4 |
salmonella enterica | 4 |
additional therapy | 4 |
hela cells | 4 |
vancomycin mic | 4 |
translational recoding | 4 |
innate protection | 4 |
rel analysis | 4 |
diabetes mellitus | 4 |
reliable bactericidal | 4 |
alpha beta | 4 |
among patients | 4 |
cellular localization | 4 |
qualitative analysis | 4 |
fatty acids | 4 |
virus nonstructural | 4 |
deubiquitinase activity | 4 |
probably due | 4 |
ning li | 4 |
lower frequency | 4 |
asian countries | 4 |
genital herpes | 4 |
emergency department | 4 |
alignment search | 4 |
plasma collection | 4 |
pseudoknot within | 4 |
using gold | 4 |
noncommunicable diseases | 4 |
readthrough stimulating | 4 |
rheumatoid arthritis | 4 |
mucosal nk | 4 |
contagious disease | 4 |
will facilitate | 4 |
potassium channels | 4 |
determined using | 4 |
fluorescence detection | 4 |
seasonal distribution | 4 |
clinical signs | 4 |
hubei province | 4 |
described previously | 4 |
murine hepatitis | 4 |
four candidate | 4 |
limited number | 4 |
globin sequences | 4 |
echinacea extracts | 4 |
series type | 4 |
cultured cells | 4 |
functional groups | 4 |
genes based | 4 |
based models | 4 |
six studies | 4 |
helix formation | 4 |
primer pairs | 4 |
reported cases | 4 |
induced acute | 4 |
virulence factors | 4 |
primer probe | 4 |
ftd respiratory | 4 |
activity toward | 4 |
group discussion | 4 |
disease outbreaks | 4 |
high affinities | 4 |
different viruses | 4 |
prrs mlv | 4 |
base pairs | 4 |
aziz medical | 4 |
bupleuri also | 4 |
study population | 4 |
analysis based | 4 |
medicinal plants | 4 |
based fluorescence | 4 |
measured using | 4 |
might lead | 4 |
liver fibrosis | 4 |
system using | 4 |
control among | 4 |
retinoic acid | 4 |
population density | 4 |
southeast region | 4 |
herbal medicine | 4 |
using spss | 4 |
growth system | 4 |
hospitalized patients | 4 |
multifactorial disease | 4 |
fractional calculus | 4 |
micromolar range | 4 |
foster city | 4 |
fluorescent signals | 4 |
expressed cd | 4 |
fourth year | 4 |
thcy concentration | 4 |
agarose gel | 4 |
bme estimation | 4 |
clinical features | 4 |
adaptive immunity | 4 |
suspected patient | 4 |
computed tomography | 4 |
stem regions | 4 |
ba genotype | 4 |
traditional surveillance | 4 |
lung disease | 4 |
per type | 4 |
blood cell | 4 |
developed beforehand | 4 |
membrane protein | 4 |
steady state | 4 |
cells treated | 4 |
communicable disease | 4 |
secretion system | 4 |
kir dl | 4 |
pandemic influenza | 4 |
room temperature | 4 |
high rate | 4 |
enzyme linked | 4 |
study group | 4 |
interview guide | 4 |
cancer drugs | 4 |
thermodynamic stability | 4 |
relapse rates | 4 |
accession number | 4 |
reduced mortality | 4 |
selected mres | 4 |
stimulated gene | 4 |
necrotic fraction | 4 |
stratified subgroups | 4 |
fluorescent based | 4 |
human nk | 4 |
free energies | 4 |
different viral | 4 |
structurally related | 4 |
values ranging | 4 |
density lipoprotein | 4 |
protein structure | 4 |
glomerular filtration | 4 |
gut nk | 4 |
baseline level | 4 |
human beta | 4 |
well known | 4 |
stable pseudoknots | 4 |
tumor size | 4 |
prospective bactericidal | 4 |
human umbilical | 4 |
acetone extract | 4 |
different fractional | 4 |
pharmacological activities | 4 |
efficient frameshifting | 4 |
adjusted odds | 3 |
quality control | 3 |
tumor virus | 3 |
information regarding | 3 |
ultrasensitive detection | 3 |
also exhibited | 3 |
mediated isothermal | 3 |
pharyngeal swabs | 3 |
binding region | 3 |
viruses may | 3 |
affinity ssdna | 3 |
adjacency matrix | 3 |
cancer treatment | 3 |
pcr reactions | 3 |
long non | 3 |
conserved motif | 3 |
unknown etiology | 3 |
conditions described | 3 |
uric acid | 3 |
streptococcus pneumoniae | 3 |
free method | 3 |
identified mre | 3 |
income countries | 3 |
also tested | 3 |
shuang ying | 3 |
rhesus macaques | 3 |
elevated serum | 3 |
prospective cohort | 3 |
kidney cells | 3 |
tumorous cells | 3 |
using multiplex | 3 |
serum total | 3 |
high prevalence | 3 |
clinical laboratory | 3 |
quantum dot | 3 |
induced gene | 3 |
four viruses | 3 |
airflow obstruction | 3 |
genetic variants | 3 |
measles infection | 3 |
quantum dots | 3 |
emerging viruses | 3 |
four candidates | 3 |
mhvjhm virus | 3 |
based methods | 3 |
etiological agent | 3 |
transmembrane helix | 3 |
multiple viruses | 3 |
post hoc | 3 |
epidemiological analysis | 3 |
several types | 3 |
showed similar | 3 |
spatial component | 3 |
cells grown | 3 |
two trial | 3 |
survival rates | 3 |
like virus | 3 |
low concentrations | 3 |
microbiological cultures | 3 |
real world | 3 |
composite spatiotemporal | 3 |
virus proteins | 3 |
upper urinary | 3 |
singlestranded dna | 3 |
circular dichroism | 3 |
lung resident | 3 |
cancer growth | 3 |
primary sequences | 3 |
water extracts | 3 |
saikosaponins isolated | 3 |
working environments | 3 |
viral particles | 3 |
biological functions | 3 |
selected using | 3 |
immature cells | 3 |
ji lu | 3 |
impedimetric aptasensor | 3 |
transcription factors | 3 |
previously proposed | 3 |
patients transfused | 3 |
tumor structures | 3 |
first interview | 3 |
higher chances | 3 |
umbilical vein | 3 |
vein endothelial | 3 |
humidified atmosphere | 3 |
neutralizing antibody | 3 |
mechanical ventilation | 3 |
multiple mechanisms | 3 |
may play | 3 |
identifying high | 3 |
several factors | 3 |
strong pseudoknots | 3 |
ii strain | 3 |
current detection | 3 |
many cases | 3 |
following day | 3 |
free methods | 3 |
disease prevention | 3 |
ml decrease | 3 |
global burden | 3 |
significant antiviral | 3 |
different pathogens | 3 |
small size | 3 |
unbound mres | 3 |
step selection | 3 |
mrna expression | 3 |
nonlocal fractional | 3 |
bupleurum falcatum | 3 |
conserved across | 3 |
viral loads | 3 |
take part | 3 |
cfx real | 3 |
significance analysis | 3 |
labor intensive | 3 |
patients hospitalized | 3 |
bulgarian patients | 3 |
plasma use | 3 |
proteins involved | 3 |
one place | 3 |
li wang | 3 |
highly specialized | 3 |
equilibrium mixtures | 3 |
citation analysis | 3 |
transmit infection | 3 |
mrna tunnel | 3 |
food safety | 3 |
several pathogens | 3 |
classical nk | 3 |
one study | 3 |
competing interests | 3 |
cryptosporidium parvum | 3 |
investigated whether | 3 |
proteins based | 3 |
severe forms | 3 |
i interferons | 3 |
recently published | 3 |
enzymatic activity | 3 |
studies included | 3 |
first identified | 3 |
will provide | 3 |
cluster together | 3 |
pulmonary infection | 3 |
adult goose | 3 |
one empty | 3 |
viral factor | 3 |
viral proteins | 3 |
also provides | 3 |
introducing pedv | 3 |
naked eye | 3 |
identified pathogen | 3 |
pcr products | 3 |
virus membrane | 3 |
tfo towards | 3 |
co humidified | 3 |
reported detection | 3 |
dna methylation | 3 |
serotype ii | 3 |
coronavirus isolate | 3 |
single cell | 3 |
cfu per | 3 |
eighteen rounds | 3 |
selex method | 3 |
support replication | 3 |
readthrough sites | 3 |
study demonstrated | 3 |
occupational stress | 3 |
low sensitivity | 3 |
transition rules | 3 |
also detected | 3 |
healthy geese | 3 |
feline coronaviruses | 3 |
human rhinovirus | 3 |
reducing relapse | 3 |
acid aptamers | 3 |
tumor microenvironment | 3 |
measurable change | 3 |
haemophilus influenzae | 3 |
virus replicated | 3 |
reticular pattern | 3 |
health centers | 3 |
lipid ii | 3 |
four classes | 3 |
foundation university | 3 |
microbead selex | 3 |
factors trigger | 3 |
therapeutic process | 3 |
natural science | 3 |
type polioviruses | 3 |
increasing threat | 3 |
enterica serovar | 3 |
small molecules | 3 |
parental virus | 3 |
urea polyacrylamide | 3 |
genomic dna | 3 |
eleven rounds | 3 |
regional laboratory | 3 |
ccl induced | 3 |
death rate | 3 |
combined therapies | 3 |
nasopharyngeal swabs | 3 |
trial groups | 3 |
recombinant swine | 3 |
pure tumor | 3 |
may occur | 3 |
dna molecules | 3 |
rad cfx | 3 |
serum therapy | 3 |
relatively large | 3 |
positive score | 3 |
seven species | 3 |
chemical structures | 3 |
environmental monitoring | 3 |
upper limit | 3 |
per phase | 3 |
capture assay | 3 |
previously identified | 3 |
specialized hospitals | 3 |
bat coronavirus | 3 |
positive conjunctival | 3 |
dna sequencing | 3 |
inhibits ifn | 3 |
pathogen surveillance | 3 |
control measure | 3 |
best results | 3 |
major source | 3 |
four strains | 3 |
immobilized mres | 3 |
recent advances | 3 |
phylogeographic study | 3 |
complete sequence | 3 |
leading cause | 3 |
lower mortality | 3 |
transfected rna | 3 |
three days | 3 |
seven adjacency | 3 |
sting dimerization | 3 |
rat model | 3 |
human tissues | 3 |
situation report | 3 |
control practices | 3 |
national natural | 3 |
vibrio parahaemolyticus | 3 |
isothermal amplification | 3 |
molecular targets | 3 |
cell proliferation | 3 |
cancer system | 3 |
chinese strains | 3 |
position paper | 3 |
extracted rna | 3 |
significantly inhibited | 3 |
table aa | 3 |
forward primer | 3 |
better understanding | 3 |
maximum likelihood | 3 |
factors including | 3 |
correlation coeff | 3 |
positive samples | 3 |
using real | 3 |
decent work | 3 |
asymptomatic carriers | 3 |
authors also | 3 |
coronavirus nl | 3 |
transmembrane helices | 3 |
gene family | 3 |
th year | 3 |
coronaviruses protein | 3 |
positive cats | 3 |
circular triple | 3 |
provides evidence | 3 |
one round | 3 |
well plates | 3 |
designed based | 3 |
several nucleotides | 3 |
smoking habit | 3 |
neisseria meningitidis | 3 |
antiviral response | 3 |
level per | 3 |
aptamers dna | 3 |
paving pattern | 3 |
sites experiencing | 3 |
free ratio | 3 |
detection based | 3 |
will take | 3 |
realtime pcr | 3 |
four polyacetylenes | 3 |
immune surveillance | 3 |
vitro bactericidal | 3 |
response seems | 3 |
cohort studies | 3 |
diseases society | 3 |
study will | 3 |
inducing apoptosis | 3 |
dental college | 3 |
quantitative merits | 3 |
cd cd | 3 |
co laser | 3 |
novel descriptor | 3 |
cell dependent | 3 |
products approved | 3 |
filtration rate | 3 |
infected individuals | 3 |
ifn response | 3 |
ifitm proteins | 3 |
swab specimens | 3 |
conformational changes | 3 |
nuclear factor | 3 |
two main | 3 |
site models | 3 |
interquartile range | 3 |
outbreak cases | 3 |
specific viruses | 3 |
nonannotated variants | 3 |
hospital environment | 3 |
related tissues | 3 |
vaginal mucosa | 3 |
viral titer | 3 |
lag coefficient | 3 |
bacterial factors | 3 |
slippery sequences | 3 |
renamed chicken | 3 |
chinese academy | 3 |
quasicontinuous double | 3 |
simian immunodeficiency | 3 |
genotype hrsv | 3 |
two cases | 3 |
induced apoptosis | 3 |
cells provide | 3 |
colorimetric assay | 3 |
highly selective | 3 |
hepatocyte injury | 3 |
see whether | 3 |
guojian pharmaceutical | 3 |
pathological features | 3 |
therapeutic application | 3 |
pcr results | 3 |
table along | 3 |
dependent ifn | 3 |
capturing element | 3 |
given patient | 3 |
among suspected | 3 |
significant impact | 3 |
phylogenetic relationships | 3 |
viral receptors | 3 |
substitution models | 3 |
vascular tone | 3 |
standardized system | 3 |
bayesian phylogeographic | 3 |
amplification efficiency | 3 |
patients recovered | 3 |
analysis revealed | 3 |
structural similarity | 3 |
chronic pancreatitis | 3 |
individual characteristics | 3 |
time step | 3 |
another experiment | 3 |
antigens related | 3 |
science type | 3 |
elementary school | 3 |
receptor expression | 3 |
healthy cats | 3 |
receptors including | 3 |
disease severity | 3 |
single microbead | 3 |
medical science | 3 |
abdul rahman | 3 |
causes severe | 3 |
rv detection | 3 |
nonlymphoid organs | 3 |
analysis indicated | 3 |
inhibiting ifn | 3 |
potassium channel | 3 |
first passage | 3 |
acute lower | 3 |
selection process | 3 |
individual interviews | 3 |
sentinel medical | 3 |
order nidovirales | 3 |
first two | 3 |
interferon gene | 3 |
saccharomyces cerevisiae | 3 |
material collected | 3 |
years old | 3 |
empirical bayes | 3 |
human natural | 3 |
envelope protein | 3 |
chronic diseases | 3 |
bioreactor system | 3 |
cell activation | 3 |
broad spectrum | 3 |
next generation | 3 |
several agents | 3 |
promoter activity | 3 |
mechanisms underlying | 3 |
identify sites | 3 |
tree obtained | 3 |
protection rate | 3 |
also developed | 3 |
frt nk | 3 |
final volume | 3 |
gene i | 3 |
dendritic cell | 3 |
different sites | 3 |
poliovirus vaccine | 3 |
typhimurium using | 3 |
bc group | 3 |
isgf nuclear | 3 |
study design | 3 |
containing radix | 3 |
study reported | 3 |
singular kernel | 3 |
three clinical | 3 |
adjacency matrices | 3 |
sequence pedv | 3 |
ct image | 3 |
tumor development | 3 |
us food | 3 |
sars epidemic | 3 |
bont type | 3 |
mature nk | 3 |
resonance energy | 3 |
viral coinfection | 3 |
dna fragments | 3 |
immunomodulatory effects | 3 |
pneumonia cases | 3 |
pcr assays | 3 |
novel virus | 3 |
five human | 3 |
day mortality | 3 |
unrelated circular | 3 |
high fever | 3 |
familial clustering | 3 |
hiv infection | 3 |
epidemic spread | 3 |
treatment group | 3 |
first days | 3 |
flow cytometry | 3 |
cells express | 3 |
effectiveness feature | 3 |
limited information | 3 |
future studies | 3 |
serum samples | 3 |
gene product | 3 |
kuan choong | 3 |
immediately downstream | 3 |
based cross | 3 |
depressive symptoms | 3 |
strain wsu | 3 |
connective tissue | 3 |
posterior pdf | 3 |
alignment editor | 3 |
mouse mammary | 3 |
electrochemical impedance | 3 |
bp fragment | 3 |
intraepithelial lymphocytes | 3 |
categorical variable | 3 |
seriously ill | 3 |
remained negative | 3 |
school pupils | 3 |
seegene inc | 3 |
cell membrane | 3 |
sequences measured | 3 |
many infectious | 3 |
protein level | 3 |
last two | 3 |
major bioactive | 3 |
group compared | 3 |
antiviral study | 3 |
chinese pedv | 3 |
current pandemic | 3 |
vibrio alginolyticus | 3 |
national center | 3 |
bacterial cell | 3 |
may attribute | 3 |
alignment analysis | 3 |
clostridium botulinum | 3 |
rna structures | 3 |
binding ability | 3 |
primers used | 3 |
cell phenotype | 3 |
personal protective | 3 |
ocular manifestation | 3 |
translocation via | 3 |
human hematopoietic | 3 |
immobilizing substrates | 3 |
highest citation | 3 |
positive bacteria | 3 |
triggers informed | 3 |
treatment reduced | 3 |
potential patient | 3 |
patients affected | 3 |
human brucellosis | 3 |
two studies | 3 |
google scholar | 3 |
maculopapular rash | 3 |
serovar typhimurium | 3 |
suppressive effect | 3 |
pathogenic bacteria | 3 |
material video | 3 |
diagnostic process | 3 |
molecular techniques | 3 |
interferon response | 3 |
ly receptors | 3 |
nine rounds | 3 |
senior dental | 3 |
translating ribosome | 3 |
strong roadblocking | 3 |
quantitative real | 3 |
studies involving | 3 |
naturally infected | 3 |
cells coinfected | 3 |
surface proteins | 3 |
amplified using | 3 |
enveloped virus | 3 |
genus bupleurum | 3 |
confidence interval | 3 |
detected frameshift | 3 |
information table | 3 |
pg ml | 3 |
nt downstream | 3 |
denaturing page | 3 |
aeruginosa infection | 3 |
light chain | 3 |
severely ill | 3 |
low doses | 3 |
nonequilibrium capillary | 3 |
scattering detection | 3 |
basic principles | 3 |
spatial transmission | 3 |
fractional orders | 3 |
pathogens using | 3 |
viral clearance | 3 |
yielded high | 3 |
high percentage | 3 |
interactive role | 3 |
resource settings | 3 |
antiviral state | 3 |
cell production | 3 |
intercontinental transmission | 3 |
arteriviridae family | 3 |
bd pharmingen | 3 |
bupleuri might | 3 |
pathogenic surveillance | 3 |
identified three | 3 |
progressively decreases | 3 |
ssdna aptamer | 3 |
international health | 3 |
red color | 3 |
septic patients | 3 |
three genes | 3 |
acute hepatitis | 3 |
situ gel | 3 |
gold electrode | 3 |
significantly upregulated | 3 |
independently associated | 3 |
toxic effect | 3 |
cancer progression | 3 |
porcine ifn | 3 |
including influenza | 3 |
chemical constituents | 3 |
datamonkey suite | 3 |
invited participants | 3 |
results demonstrated | 3 |
drug resistance | 3 |
pathological findings | 3 |
catalytic activity | 3 |
fluorescence resonance | 3 |
adipose tissue | 3 |
tumor necrosis | 3 |
based approach | 3 |
pulmonary alveolar | 3 |
chronic inflammation | 3 |
greater risk | 3 |
necrotic cells | 3 |
fluorescent aptasensor | 3 |
one hand | 3 |
showed significant | 3 |
aspirate cultures | 3 |
whole number | 3 |
definitive diagnoses | 3 |
jev strains | 3 |
enrichment kit | 3 |
patients presenting | 3 |
method based | 3 |
target causes | 3 |
immature phenotype | 3 |
spatial lag | 3 |
relapse risk | 3 |
defa defa | 3 |
binding protein | 3 |
type prrsv | 3 |
susceptibility testing | 3 |
rat plasma | 3 |
viral diseases | 3 |
internal mutation | 3 |
recently described | 3 |
first perspective | 3 |
ii feline | 3 |
nitric oxide | 3 |
fipv infection | 3 |
selection scheme | 3 |
expression level | 3 |
target bound | 3 |
brucella melitensis | 3 |
symptoms reported | 3 |
redox current | 3 |
energy transfer | 3 |
clinical development | 3 |
also used | 3 |
mab approved | 3 |
liberation army | 3 |
lamina propria | 3 |
based aptasensor | 3 |
gamma production | 3 |
less stable | 3 |
gag termination | 3 |
acid sequence | 3 |
wide spectrum | 3 |
organophosphorus pesticides | 3 |
normal distribution | 3 |
binding affinities | 3 |
silico maturation | 3 |
studied population | 3 |
structural studies | 3 |
family coronaviridae | 3 |
injury associated | 3 |
resulted negative | 3 |
left right | 3 |
hu decoction | 3 |
clinical data | 3 |
included patients | 3 |
positive target | 3 |
low level | 3 |
elevated vancomycin | 3 |
mab development | 3 |
virus isolated | 3 |
baked radix | 3 |
million people | 3 |
european populations | 3 |
mutant genes | 3 |
aptamer selection | 3 |
infants hospitalized | 3 |
high risk | 3 |
defensin gene | 3 |
specific toward | 3 |
pathogen detection | 3 |
homologous recombination | 3 |
binding domain | 3 |
new therapeutic | 3 |
target antigens | 3 |
laboratory testing | 3 |
linear tfos | 3 |
outbreak events | 3 |
army general | 3 |
ranked potential | 3 |
interferon induction | 3 |
tissue distribution | 3 |
protein similarity | 3 |
will see | 3 |
another important | 3 |
evaporative light | 3 |
mrna level | 3 |
aureus atcc | 3 |
damaging effect | 3 |
similar sequences | 3 |
ordinary differential | 3 |
briefly discussed | 3 |
membrane potential | 3 |
severe disease | 3 |
prrsv interference | 3 |
genome replication | 3 |
blood vessels | 3 |
matched case | 3 |
respiratory aspirate | 3 |
food products | 3 |
biopsy examinations | 3 |
sine hole | 3 |
person contagious | 3 |
lower level | 3 |
subgenomic dna | 3 |
antiviral isgs | 3 |
scientific understanding | 3 |
job satisfaction | 3 |
human monoclonal | 3 |
authors concluded | 3 |
respiratory diseases | 3 |
intracranial aneurysms | 3 |
total homocysteine | 3 |
mixed target | 3 |
novel method | 3 |
parvum infection | 3 |
control strain | 3 |
ocular findings | 3 |
mortality rates | 3 |
confidence intervals | 3 |
economic losses | 3 |
analytical sensitivity | 3 |
pcr test | 3 |
wide analysis | 3 |
coated beads | 3 |
almost half | 3 |
economic crisis | 3 |
also nsp | 3 |
aa ar | 3 |
otu domain | 3 |
current situation | 3 |
traditional medicine | 3 |
case fatality | 3 |
topologies obtained | 3 |
correlation coefficient | 3 |
empty place | 3 |
nsp encodes | 3 |
severe covid | 3 |
kill assays | 3 |
gallus ifitm | 3 |
preterm neonates | 3 |
viral mrnas | 3 |
hospital stay | 3 |
high potential | 3 |
mediated ifn | 3 |
forest virus | 3 |
cd dcs | 3 |
reporter assay | 3 |
target immobilization | 3 |
clinical samples | 3 |
two proteins | 3 |
association analysis | 3 |
western blot | 3 |
scorzonerifolium willd | 3 |
synthesized using | 3 |
human immunoglobulin | 3 |
producing ifn | 3 |
dissimilarity among | 3 |
chronic obstructive | 3 |
cells resemble | 3 |
feces samples | 3 |
demographic markers | 3 |
cancer risk | 3 |
virological surveillance | 3 |
cancer precision | 3 |
severe course | 3 |
high levels | 3 |
popular targets | 3 |
mammary tumor | 3 |
phase ii | 3 |
new viruses | 3 |
plasmid dna | 3 |
cross infection | 3 |
accession code | 3 |
skin rash | 3 |
molecular probes | 3 |
basement membrane | 3 |
unfolding threats | 3 |
extended condylomatosis | 3 |
comprehensive review | 3 |
table show | 3 |
summer season | 3 |
cancer institute | 3 |
possesses deubiquitinating | 3 |
bright cd | 3 |
cause serious | 3 |
respiratory coronavirus | 3 |
descriptive study | 3 |
well described | 3 |
lab results | 3 |
gene encoding | 3 |
highly sensitive | 3 |
pol gene | 3 |
urban areas | 3 |
beta interferon | 3 |
human uterine | 3 |
retroviridae family | 3 |
sars dynamics | 3 |
gag reading | 3 |
resident cells | 3 |
control strategies | 3 |
new method | 3 |
mre showed | 3 |
antibody production | 3 |
first mab | 3 |
okadaic acid | 3 |
included infants | 3 |
positive pcr | 3 |
computational oncology | 3 |
mrna sequence | 3 |
different genotypes | 3 |
china epidemiological | 3 |
factor receptor | 3 |
tukey post | 3 |
standard curve | 3 |
genital tract | 3 |
also introduced | 3 |
diploid cells | 3 |
similarity matrix | 3 |
inhibited ifn | 3 |
also amplified | 3 |
complement activation | 3 |
several countries | 3 |
evaluated based | 3 |
pcb compounds | 3 |
liver protective | 3 |
binding buffer | 3 |
antibody drug | 3 |
whole cells | 3 |
mild covid | 3 |
antiviral innate | 3 |
antimicrobial peptide | 3 |
takes place | 3 |
specific preparedness | 3 |
condylomatosis extension | 3 |
different healthcare | 3 |
may provide | 3 |
rna accumulation | 3 |
blood products | 3 |
outpatient clinics | 3 |
well plate | 3 |
food matrices | 3 |
health authorities | 3 |
library molecules | 3 |
super spreaders | 3 |
studies demonstrated | 3 |
registered permanent | 3 |
specific regions | 3 |
bovine viral | 3 |
high performance | 3 |
cells develop | 3 |
similar results | 3 |
standardized preparedness | 3 |
cov pl | 3 |
primate lentiviruses | 3 |
ineffective sterilization | 3 |
clinical applications | 3 |
developed countries | 3 |
ethical committee | 3 |
infected group | 3 |
random field | 3 |
measles virus | 3 |
rhesus macaque | 3 |
one ratio | 3 |
major groove | 3 |
vegf monoclonal | 3 |
dna mres | 3 |
pairwise sequence | 3 |
pairwise identity | 3 |
considered model | 3 |
mg kg | 3 |
qualitative comparison | 3 |
health commission | 3 |
antibody titers | 3 |
mic values | 3 |
biosensor based | 3 |
define preparedness | 3 |
retrospective cohort | 3 |
reporting mre | 3 |
single reaction | 3 |
high sensitivity | 3 |
articles according | 3 |
much less | 3 |
long sequences | 3 |
hole spatial | 3 |
virus vaccine | 3 |
assays showed | 3 |
downstream pseudoknot | 3 |
irf signaling | 3 |
fin whale | 3 |
protective immunity | 3 |
class ii | 3 |
medical history | 3 |
sars infections | 3 |
common chimpanzee | 3 |
two random | 3 |
angiotensin ii | 3 |
combined group | 3 |
negative bacterium | 3 |
based biosensor | 3 |
enzymatic proteins | 3 |
rna sequences | 3 |
mrna pseudoknot | 3 |
stem cell | 3 |
possible deleterious | 3 |
clinical improvement | 3 |
two cis | 3 |
considered tissue | 3 |
inactivated poliovirus | 3 |
measures among | 3 |
virus rna | 3 |
underlying mechanisms | 3 |
show samples | 3 |
binding assays | 3 |
drug therapy | 3 |
also cause | 3 |
mrsa isolates | 3 |
fcov genome | 3 |
following two | 3 |
little effect | 3 |
infection preventionists | 3 |
cell cycle | 3 |
dependent enhancement | 3 |
adjusted ors | 3 |
medical managers | 3 |
obstructive pulmonary | 3 |
way anova | 3 |
elisa using | 3 |
inflammatory activity | 3 |
hoc test | 3 |
aristolochic acid | 3 |
biotinylated mres | 3 |
human tumor | 3 |
two potential | 3 |
recognition element | 3 |
anthrax spores | 3 |
selected somamers | 3 |
fel analysis | 3 |
relations among | 3 |
stat nuclear | 3 |
protective equipment | 3 |
test results | 3 |
less likely | 3 |
unknown viruses | 3 |
different rates | 3 |
selection pressure | 3 |
also contribute | 3 |
cell death | 3 |
highly pathogenic | 3 |
rapid adenovirus | 3 |
disease course | 3 |
pharmaceutical co | 3 |
specific treatment | 3 |
three disulphide | 3 |
murine mabs | 3 |
stimulating ability | 3 |
critical role | 3 |
nextera exome | 3 |
marburg virus | 3 |
become one | 3 |
wall biosynthesis | 3 |
clear exposure | 3 |